BTIG raises CareDx price target to $81
The raised target indicates a positive analyst view and notable indicated upside, but the missing prior target limits assessment of the change.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The raised target indicates a positive analyst view and notable indicated upside, but the missing prior target limits assessment of the change.
What happened, with direct paths to the underlying reporting
BTIG raised its CDNA price target to $81 from an unstated prior level. The posted price was $69.10, about 17% below the new target.
Target: $81
Posted price: $69.1
Analyst firm: BTIG
Analyst: Sung Ji Nam
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.